455 related articles for article (PubMed ID: 22412055)
1. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.
Andes DR; Safdar N; Baddley JW; Playford G; Reboli AC; Rex JH; Sobel JD; Pappas PG; Kullberg BJ;
Clin Infect Dis; 2012 Apr; 54(8):1110-22. PubMed ID: 22412055
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
[TBL] [Abstract][Full Text] [Related]
3. Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy?
Leenders NH; Oosterheert JJ; Ekkelenkamp MB; De Lange DW; Hoepelman AI; Peters EJ
Int J Infect Dis; 2011 Jul; 15(7):e453-8. PubMed ID: 21530350
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital].
Yenigün Koçak B; Kuloğlu F; Doğan Çelik A; Akata F
Mikrobiyol Bul; 2011 Jul; 45(3):489-503. PubMed ID: 21935782
[TBL] [Abstract][Full Text] [Related]
5. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
Shorr AF; Wu C; Kothari S
J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis Infections: a meta-analysis.
Kale-Pradhan PB; Morgan G; Wilhelm SM; Johnson LB
Pharmacotherapy; 2010 Dec; 30(12):1207-13. PubMed ID: 21114387
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis.
Neoh CF; Liew D; Slavin M; Marriott D; Chen SC; Morrissey O; Stewart K; Kong DC
J Antimicrob Chemother; 2011 Aug; 66(8):1906-15. PubMed ID: 21628305
[TBL] [Abstract][Full Text] [Related]
9. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
[TBL] [Abstract][Full Text] [Related]
10. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.
Grim SA; Berger K; Teng C; Gupta S; Layden JE; Janda WM; Clark NM
J Antimicrob Chemother; 2012 Mar; 67(3):707-14. PubMed ID: 22184469
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
12. Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives.
Neoh CF; Slavin M; Chen SC; Stewart K; Kong DC
Int J Antimicrob Agents; 2014 Mar; 43(3):207-14. PubMed ID: 24670423
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
[TBL] [Abstract][Full Text] [Related]
14. Impact of initial empirical antifungal agents on the outcome of critically ill patients with invasive candidiasis: analysis of the China-SCAN study.
Cui N; Wang H; Qiu H; Li R; Liu D
Int J Antimicrob Agents; 2017 Jul; 50(1):74-80. PubMed ID: 28499959
[TBL] [Abstract][Full Text] [Related]
15. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
[TBL] [Abstract][Full Text] [Related]
16. Adult candidemia at a medical center in northern Taiwan: a retrospective study.
Tsai CC; Wang CC; Kuo HY; Chiang DH; Lin ML; Liu CY; Yang SP
J Microbiol Immunol Infect; 2008 Oct; 41(5):414-21. PubMed ID: 19122924
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of candidemia and invasive candidiasis according to guidelines].
Glöckner A
Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
19. Anidulafungin: a new echinocandin with a novel profile.
Vazquez JA
Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
[TBL] [Abstract][Full Text] [Related]
20. Echinocandin use in the neonatal intensive care unit.
Caudle KE; Inger AG; Butler DR; Rogers PD
Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
